Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
J Cancer Res Clin Oncol ; 117(6): 526-32, 1991.
Artigo em Inglês | MEDLINE | ID: mdl-1744157

RESUMO

The N-methyl-N-nitrosourea (NMU) model of hormone-responsive rat mammary carcinogenesis was used to address the hypothesis that melatonin (Mel), the principle hormone of the pineal gland, inhibits tumorigenesis by acting as an anti-promoting rather than an anti-initiating agent. Daily late-afternoon injections of Mel (500 micrograms/day), restricted to the initiation phase of NMU mammary tumorigenesis, were ineffective in altering tumor growth over a 20-week period. When Mel treatment was delayed for 4 weeks after NMU and then continued through the remainder of the promotion phase, only tumor number was significantly lower than in controls. However, when Mel injections encompassed the entire promotion phase, both tumor incidence and number were significantly lower than in the controls. Although elimination of the endogenous Mel signal via pinealectomy promoted tumor growth, the effect was not statistically significant. Serum levels of estradiol and tumor estrogen receptor content were unaltered by either Mel or pinealectomy. While Mel treatment failed to affect circulating prolactin levels, pinealectomy caused a two-fold increase in serum prolactin. The estradiol-stimulated recrudescence of tumors following ovariectomy was completely blocked by either 20, 100 or 500 micrograms Mel/day or tamoxifen (20 micrograms/day). Thus, Mel appears to be an anti-promoting hormone that may antagonize the tumor-promoting actions of estradiol in this model of mammary tumorigenesis.


Assuntos
Neoplasias Mamárias Experimentais/tratamento farmacológico , Melatonina/farmacologia , Animais , Modelos Animais de Doenças , Estradiol/sangue , Feminino , Neoplasias Mamárias Experimentais/metabolismo , Metilnitrosoureia , Camundongos , Recidiva Local de Neoplasia/tratamento farmacológico , Ovariectomia , Glândula Pineal/metabolismo , Glândula Pineal/cirurgia , Prolactina/sangue , Radioimunoensaio , Receptores de Estrogênio/biossíntese , Tamoxifeno/farmacologia
2.
J Cell Physiol ; 158(3): 427-34, 1994 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-8126067

RESUMO

Gap junction-mediated intercellular communication (GJC) may play an important role in cell proliferation and transformation since GJC is inhibited by growth factors, oncogenes, tumor promoters, and carcinogens. We have studied inhibition of GJC by platelet-derived growth factor-BB (PDGF) in the mouse fibroblast cell line C3H/10T1/2 and have sought to determine whether PDGF-induced inhibition of GJC is mediated by the PDGF receptor tyrosine kinase (RTK). PDGF-mediated inhibition of GJC was rapid and transient, with maximal inhibition occurring 40 min after PDGF addition and GJC returning to control levels after 70 min. The effect of PDGF on GJC was concentration-dependent, with maximal inhibition of 90% or greater occurring at 10 ng/ml PDGF. Stimulation of RTK activity, as determined by antiphosphotyrosine immunoblot analysis of PDGF receptor and the receptor substrates phospholipase C-gamma I (PLC-gamma I) and guanosine triphosphatase activating protein (GAP), was also concentration-dependent. Inhibition of GJC required a greater concentration of PDGF than did stimulation of RTK activity. The tyrosine kinase inhibitor genistein blocked PDGF-induced RTK activity, as measured by PDGF receptor, PLC-gamma I, and GAP tyrosine phosphorylation, in a concentration-dependent manner but did not affect PDGF-mediated inhibition of GJC. Genistein alone had no effect on GJC or PDGF receptor expression. PDGF treatment in the presence or absence of genistein resulted in phosphorylation of the connexin 43 protein on nontyrosine residues. These results suggest that inhibition of GJC by ligand-activated PDGF receptor is dissociable from the RTK activity responsible for PDGF, PLC-gamma I, and GAP phosphorylation.


Assuntos
Fibroblastos/citologia , Junções Comunicantes/fisiologia , Fator de Crescimento Derivado de Plaquetas/farmacologia , Proteínas Tirosina Quinases/fisiologia , Receptores do Fator de Crescimento Derivado de Plaquetas/fisiologia , Animais , Comunicação Celular/fisiologia , Linhagem Celular , Conexina 43/metabolismo , Relação Dose-Resposta a Droga , Fibroblastos/fisiologia , Fibroblastos/ultraestrutura , Proteínas Ativadoras de GTPase , Genisteína , Isoflavonas/farmacologia , Camundongos , Fator de Crescimento Derivado de Plaquetas/metabolismo , Fator de Crescimento Derivado de Plaquetas/fisiologia , Testes de Precipitina , Proteínas Tirosina Quinases/antagonistas & inibidores , Proteínas/metabolismo , Proteínas/fisiologia , Fatores de Tempo , Fosfolipases Tipo C/metabolismo , Fosfolipases Tipo C/fisiologia
3.
J Neural Transm Gen Sect ; 82(1): 1-9, 1990.
Artigo em Inglês | MEDLINE | ID: mdl-2206487

RESUMO

The effects of MSG on PRL cell activity in hamsters was assessed by injecting either MSG (8 mg/g body weight) or saline into male and female hamsters on day 8 of the neonatal period. One-hundred and three days later, the anterior pituitaries were removed for the analysis of PRL synthesis and storage. Serum PRL levels were also determined by radioimmunoassay as an index of in vivo PRL secretion. Blood levels of PRL were decreased by 74% in female and 88% in male hamsters treated with MSG as compared with vehicle controls. In females, glutamate induced a drop in PRL storage (90%) and synthesis (82%) while in male animals glutamate caused a non-significant decrease in PRL storage (48%) and synthesis (31%) as compared with controls. These results indicate that MSG-induced arcuate nucleus lesions inhibit PRL cell activity in the hamster.


Assuntos
Sistemas Neurossecretores/fisiologia , Prolactina/metabolismo , Glutamato de Sódio/farmacologia , Animais , Animais Recém-Nascidos , Cricetinae , Feminino , Genitália/anatomia & histologia , Masculino , Mesocricetus , Tamanho do Órgão/efeitos dos fármacos , Hipófise/metabolismo , Adeno-Hipófise/anatomia & histologia , Prolactina/análise , Prolactina/sangue
4.
Cell Growth Differ ; 6(6): 681-90, 1995 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-7669722

RESUMO

Communication between adjacent cells through gap junctions is believed to be involved in the regulation of cell proliferation. This stems in part from the observation that transfection and overexpression of connexin (cx) 32 or cx43 genes into neoplastic cells lead to normalization of growth and decrease their tumorigenicity. The molecular mechanism(s) responsible for this phenomenon has not been characterized. We transfected the rat cx43 gene into a phenotypically transformed dog kidney epithelial cell line, TRMP, and were successful in restoring gap junctional communication as measured by dye coupling. In addition, cx43-transfected clones reverted to a flat morphology and were sensitive to density-dependent inhibition of proliferation with their G1 and S phase duration almost doubled. These cx43-induced effects were coupled with a decreased expression of specific cell cycle regulatory genes critical to cell cycle progression in nonneoplastic cells including cyclin A, D1, D2, and the cyclin-dependent kinases (CDK) 5 and CDK6. The protein levels of cyclin E, CDK2, and CDK4 were not affected. These results suggest that overexpression of cx43 and the formation of gap junctions with the establishment of gap junctional communication can affect the phenotype of transformed cells and alter specific gene expressions involved in cell cycle regulation.


Assuntos
Transformação Celular Neoplásica/efeitos dos fármacos , Conexina 43/farmacologia , Quinases Ciclina-Dependentes/biossíntese , Ciclinas/biossíntese , Junções Comunicantes/efeitos dos fármacos , Regulação Neoplásica da Expressão Gênica/efeitos dos fármacos , Proteínas de Neoplasias/biossíntese , Animais , Divisão Celular/efeitos dos fármacos , Linhagem Celular Transformada/efeitos dos fármacos , Inibição de Contato/efeitos dos fármacos , Cricetinae , Quinases Ciclina-Dependentes/genética , Ciclinas/genética , Cães , Indução Enzimática/efeitos dos fármacos , Fase G1/efeitos dos fármacos , Junções Comunicantes/fisiologia , Rim , Fígado , Proteínas de Neoplasias/genética , Fenótipo , Coelhos , Ratos , Proteínas Recombinantes/metabolismo , Fase S/efeitos dos fármacos , Transfecção
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA